AUPH FY2025 SEC EDGAR DEF 14A #132 of 168 in industry

Aurinia Pharmaceuticals Inc. CEO pay ratio

The CEO earned $320K in FY2025 against median worker pay of $320,246 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
A1
Filing date
2026-04-21
Industry
Chemicals & Pharmaceuticals
Industry rank
#132/168

Data updated August 2026

Subscribe to Aurinia Pharmaceuticals Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
18:1
Below Average (Scale: 0–1000:1)
CEO pay
$320K
Median worker
$320,246

Answer first

Aurinia Pharmaceuticals Inc.'s FY2025 CEO total of $320K ranks #1306 of 1,423 complete filings; its 18:1 pay ratio ranks #1227. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $320,246. Industry placement uses the FY2025 SIC-28 peer cohort (# 132 of 168, 22nd percentile - among the lower quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#1306
$320K of 1,423 FY2025
Ratio rank
#1227
18:1 of 1,423
Industry pct
22nd
among the lower quartile of industry peers by pay ratio

How Aurinia Pharmaceuticals Inc. ranks nationally

Aurinia Pharmaceuticals Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$320,246 8th percentile higher than 8% of 1,423 companies

$0–$2,500,000: 304 companies (21%). This entry sits in this band. $2,500,000–$5,000,000: 182 companies (13%). Above this entry. $5,000,000–$7,500,000: 208 companies (15%). Above this entry. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Aurinia Pharmaceuticals Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($320K) against pay ratio (18:1) for Aurinia Pharmaceuticals Inc. (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both02690243.95380487.88070731.710760975.615.8:122.6:129.5:136.4:143.3:1CEO total payPay ratio (CEO : median worker)Aurinia Pharmaceuticals Inc., CEO total pay: 320246 · Pay ratio (CEO : median worker): 18:1Aurinia Pharmaceuticals Inc.Agios Pharmaceuticals, Inc., CEO total pay: 5456520 · Pay ratio (CEO : median worker): 18:1Agios Pharmaceuticals, Inc.Disc Medicine, Inc., CEO total pay: 10263798 · Pay ratio (CEO : median worker): 18:1Disc Medicine, Inc.Syndax Pharmaceuticals Inc, CEO total pay: 7281788 · Pay ratio (CEO : median worker): 19:1Syndax Pharmaceuticals IncuniQure N.V., CEO total pay: 3287434 · Pay ratio (CEO : median worker): 19:1uniQure N.V.Intellia Therapeutics, Inc., CEO total pay: 5117748 · Pay ratio (CEO : median worker): 17:1Intellia Therapeutics, Inc.
Aurinia Pharmaceuticals Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Aurinia Pharmaceuticals Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Aurinia Pharmaceuticals Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
18:1
FY2025
vs prior FY
-2:1
from FY2024 20:1
CEO $ YoY
+0.3%
$320K latest
Filings shown
5
FY2021–2025
Aurinia Pharmaceuticals Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $255K - $255,489 5:1 -
2022 $265K +3.8% $265,164 33:1 +28:1
2023 $304K +15% $303,646 35:1 +2:1
2024 $319K +5.1% $319,139 20:1 -15:1
2025 $320K +0.3% $320,246 18:1 -2:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1600620, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
18:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$320K
Companies in Industry
168
vs. Industry Median
Below
#132 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Aurinia Pharmaceuticals Inc.: near-parity Item 402(u) ratio

Aurinia Pharmaceuticals Inc.'s FY2025 ratio 18:1 ranks #132 of 168 Chemicals & Pharmaceuticals filers (22nd percentile). the CEO earned 18× the median employee ($320,246) in FY2025.

At $320,246 median worker pay, the FLOOR stamp is near pay-parity territory under MICRO CEO total.

CEO Total Pay

$320K

FY2025 Summary Compensation, below median

Pay Ratio

18:1

Below typical

Aurinia Pharmaceuticals Inc. in the lower Chemicals & Pharmaceuticals third

Aurinia Pharmaceuticals Inc.'s FY2025 ratio 18:1 ranks #132 of 168 Chemicals & Pharmaceuticals filers (22nd percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Aurinia Pharmaceuticals Inc.'s $320K CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #1306 and ratio rank #1227 split - treat 18:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$320K
Median Employee Pay
$320,246
Pay Ratio
18:1
Filing Date
2026-04-21

Company Info

Ticker
AUPH
CIK
1600620
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
A1
View SEC filings →
SEC EDGAR DEF 14A for CIK 1600620, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Aurinia Pharmaceuticals Inc.'s FY2025 ratio 18:1 ranks #132 of 168 Chemicals & Pharmaceuticals filers (22nd percentile).

Read with Aurinia Pharmaceuticals Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps FLOOR · MICRO · ELITE-MED.

Alexanders Inc · MICRO

ABS(ceo_total_comp) peer at $321K (Δ $1K heavier vs Aurinia Pharmaceuticals Inc.); FLOOR · HIGH-MED vs this page's FLOOR · MICRO · ELITE-MED.
Geron Corp · MICRO

ABS(ceo_total_comp) peer at $315K (Δ $5K lighter vs Aurinia Pharmaceuticals Inc.); MODEST · LOW-MED vs this page's FLOOR · MICRO · ELITE-MED.
Wintrust Financial Corp · MICRO

ABS(ceo_total_comp) peer at $326K (Δ $6K heavier vs Aurinia Pharmaceuticals Inc.); FLOOR · HIGH-MED vs this page's FLOOR · MICRO · ELITE-MED.
Arvinas, Inc. · MICRO

ABS(ceo_total_comp) peer at $328K (Δ $7K heavier vs Aurinia Pharmaceuticals Inc.); FLOOR · ELITE-MED vs this page's FLOOR · MICRO · ELITE-MED.
Agios Pharmaceuticals, Inc. (SIC 28 pole)

Agios Pharmaceuticals, Inc. stamps FLOOR · MID$ nearest in-SIC by ABS(pay_ratio) to Aurinia Pharmaceuticals Inc.'s FLOOR filing.
National dual ranks · #1306/#1227

Aurinia Pharmaceuticals Inc.'s FY2025 package sits #1306 by CEO dollars and #1227 by ratio under MICRO · FLOOR.
Ratio primer · FLOOR

Aurinia Pharmaceuticals Inc.'s FLOOR stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Aurinia Pharmaceuticals Inc. (CIK 1600620), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.